Form 4: Vor Biopharma Executive Amy Quinlan Reports Tax Withholding Transaction
SEC Form 4 Filing
Amy Quinlan, Vice President of Finance at Vor Biopharma, reports the withholding of shares to cover tax obligations related to the settlement of restricted stock units.
Summary
- On November 1, 2024, Amy Quinlan, Vice President of Finance at Vor Biopharma Inc., had 343 shares of common stock withheld to satisfy tax obligations.
- This transaction occurred in connection with the settlement of restricted stock units.
- Following the transaction, Quinlan beneficially owns 50,518 shares of Vor Biopharma Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to tax withholding, indicating a neutral sentiment.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 11/01/2024 | Date of the transaction where shares were withheld for tax obligations. |
| 11/05/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.